Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the most suitable dose of Oxaliplatin that can be
safely given in combination with a low fixed dose of Capecitabine and a limited volume of
radiation in patients with non-small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center Sanofi University of Louisville